PARP1: Structural insights and pharmacological targets for inhibition
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
PARP1: Structural insights and pharmacological targets for inhibition
Authors
Keywords
PARP1, DNA repair, Cancer, Chemotherapy, Drug resistance, Review
Journal
DNA REPAIR
Volume 103, Issue -, Pages 103125
Publisher
Elsevier BV
Online
2021-04-15
DOI
10.1016/j.dnarep.2021.103125
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- HPF1 remodels the active site of PARP1 to enable the serine ADP-ribosylation of histones
- (2021) Fa-Hui Sun et al. Nature Communications
- Histone Parylation factor 1 contributes to the inhibition of PARP1 by cancer drugs
- (2021) Johannes Rudolph et al. Nature Communications
- Detection of molecular signatures of homologous recombination deficiency in prostate cancer with or without BRCA1/2 mutations
- (2020) Zsofia Sztupinszki et al. CLINICAL CANCER RESEARCH
- PARP inhibitors in pancreatic cancer: molecular mechanisms and clinical applications
- (2020) Heng Zhu et al. Molecular Cancer
- HPF1 completes the PARP active site for DNA damage-induced ADP-ribosylation
- (2020) Marcin J. Suskiewicz et al. NATURE
- Combined PARP and ATR inhibition potentiates genome instability and cell death in ATM-deficient cancer cells
- (2020) Rebecca L. Lloyd et al. ONCOGENE
- Structural basis for allosteric PARP-1 retention on DNA breaks
- (2020) Levani Zandarashvili et al. SCIENCE
- AutoGrow4: an open-source genetic algorithm for de novo drug design and lead optimization
- (2020) Jacob O. Spiegel et al. Journal of Cheminformatics
- Bridging of DNA breaks activates PARP2–HPF1 to modify chromatin
- (2020) Silvija Bilokapic et al. NATURE
- Clinical PARP inhibitors do not abrogate PARP1 exchange at DNA damage sites in vivo
- (2020) Zhengping Shao et al. NUCLEIC ACIDS RESEARCH
- PARP Inhibitors: Clinical Relevance, Mechanisms of Action and Tumor Resistance
- (2020) Maddison Rose et al. Frontiers in Cell and Developmental Biology
- Poly(ADP-ribosyl)ation by PARP1: reaction mechanism and regulatory proteins
- (2019) Elizaveta E Alemasova et al. NUCLEIC ACIDS RESEARCH
- Design and Synthesis of Poly(ADP-ribose) Polymerase Inhibitors: Impact of Adenosine Pocket-Binding Motif Appendage to the 3-Oxo-2,3-dihydrobenzofuran-7-carboxamide on Potency and Selectivity
- (2019) Uday Kiran Velagapudi et al. JOURNAL OF MEDICINAL CHEMISTRY
- Hit and run versus long-term activation of PARP-1 by its different domains fine-tunes nuclear processes
- (2019) Colin Thomas et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Eukaryotic Base Excision Repair: New Approaches Shine Light on Mechanism
- (2019) William A. Beard et al. Annual Review of Biochemistry
- Mammalian DNA Polymerase Kappa Activity and Specificity
- (2019) Hannah R. Stern et al. MOLECULES
- Poly(ADP-ribose) polymerase enzymes and the maintenance of genome integrity
- (2019) Travis Eisemann et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Choosing wisely: Selecting PARP inhibitor combinations to promote anti-tumor immune responses beyond BRCA mutations
- (2019) Jennifer Taylor Veneris et al. GYNECOLOGIC ONCOLOGY
- PARP Inhibitor Resistance: A Tug-of-War in BRCA-Mutated Cells
- (2019) Sylvie M. Noordermeer et al. TRENDS IN CELL BIOLOGY
- The Enigmatic Function of PARP1: From PARylation Activity to PAR Readers
- (2019) Tatiana Kamaletdinova et al. Cells
- Multifaceted Role of PARP-1 in DNA Repair and Inflammation: Pathological and Therapeutic Implications in Cancer and Non-Cancer Diseases
- (2019) Simonetta Pazzaglia et al. Cells
- Co-targeting poly(ADP-ribose) polymerase (PARP) and histone deacetylase (HDAC) in triple-negative breast cancer: Higher synergism in BRCA mutated cells
- (2018) Hélène Marijon et al. BIOMEDICINE & PHARMACOTHERAPY
- PARP inhibitors in breast cancer: Bringing synthetic lethality to the bedside
- (2018) Anita A. Turk et al. CANCER
- Selective Loss of PARG Restores PARylation and Counteracts PARP Inhibitor-Mediated Synthetic Lethality
- (2018) Ewa Gogola et al. CANCER CELL
- FDA Approval Summary: Niraparib for the Maintenance Treatment of Patients with Recurrent Ovarian Cancer in Response to Platinum-Based Chemotherapy
- (2018) Gwynn Ison et al. CLINICAL CANCER RESEARCH
- Design and synthesis of 2-(4,5,6,7-tetrahydrothienopyridin-2-yl)-benzoimidazole carboxamides as novel orally efficacious Poly(ADP-ribose)polymerase (PARP) inhibitors
- (2018) Xuxing Chen et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Homologous recombination and the repair of DNA double-strand breaks
- (2018) William Douglass Wright et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Importance of Poly(ADP-Ribose) Polymerase as a Sensor of Unligated Okazaki Fragments during DNA Replication
- (2018) Hana Hanzlikova et al. MOLECULAR CELL
- NAD+ analog reveals PARP-1 substrate-blocking mechanism and allosteric communication from catalytic center to DNA-binding domains
- (2018) Marie-France Langelier et al. Nature Communications
- Genome-wide and high-density CRISPR-Cas9 screens identify point mutations in PARP1 causing PARP inhibitor resistance
- (2018) Stephen J. Pettitt et al. Nature Communications
- Serine is the major residue for ADP-ribosylation upon DNA damage
- (2018) Luca Palazzo et al. eLife
- BlendMol: advanced macromolecular visualization in Blender
- (2018) Jacob D Durrant BIOINFORMATICS
- Talazoparib: First Global Approval
- (2018) Sheridan M. Hoy DRUGS
- PARP1 Trapping by PARP Inhibitors Drives Cytotoxicity in Both Cancer Cells and Healthy Bone Marrow
- (2018) Todd A. Hopkins et al. MOLECULAR CANCER RESEARCH
- Targeting BRCA Deficiency in Breast Cancer: What are the Clinical Evidences and the Next Perspectives?
- (2018) Emanuel Nicolas et al. Cancers
- Mechanisms of DNA damage, repair, and mutagenesis
- (2017) Nimrat Chatterjee et al. ENVIRONMENTAL AND MOLECULAR MUTAGENESIS
- ATR inhibition disrupts rewired homologous recombination and fork protection pathways in PARP inhibitor-resistant BRCA-deficient cancer cells
- (2017) Stephanie A. Yazinski et al. GENES & DEVELOPMENT
- PARP inhibitors: Clinical utility and possibilities of overcoming resistance
- (2017) Benjamin G. Bitler et al. GYNECOLOGIC ONCOLOGY
- Non-homologous DNA end joining and alternative pathways to double-strand break repair
- (2017) Howard H. Y. Chang et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- PARP1 changes from three-dimensional DNA damage searching to one-dimensional diffusion after auto-PARylation or in the presence of APE1
- (2017) Lili Liu et al. NUCLEIC ACIDS RESEARCH
- Secondary Somatic Mutations Restoring RAD51C and RAD51D Associated with Acquired Resistance to the PARP Inhibitor Rucaparib in High-Grade Ovarian Carcinoma
- (2017) Olga Kondrashova et al. Cancer Discovery
- Circulating Cell-Free DNA to Guide Prostate Cancer Treatment with PARP Inhibition
- (2017) Jane Goodall et al. Cancer Discovery
- The Role of the Core Non-Homologous End Joining Factors in Carcinogenesis and Cancer
- (2017) et al. Cancers
- Structural Basis for Potency and Promiscuity in Poly(ADP-ribose) Polymerase (PARP) and Tankyrase Inhibitors
- (2016) Ann-Gerd Thorsell et al. JOURNAL OF MEDICINAL CHEMISTRY
- HPF1/C4orf27 Is a PARP-1-Interacting Protein that Regulates PARP-1 ADP-Ribosylation Activity
- (2016) Ian Gibbs-Seymour et al. MOLECULAR CELL
- Replication fork stability confers chemoresistance in BRCA-deficient cells
- (2016) Arnab Ray Chaudhuri et al. NATURE
- Blocking c-Met–mediated PARP1 phosphorylation enhances anti-tumor effects of PARP inhibitors
- (2016) Yi Du et al. NATURE MEDICINE
- Functions of PARylation in DNA Damage Repair Pathways
- (2016) Huiting Wei et al. GENOMICS PROTEOMICS & BIOINFORMATICS
- BRCAness Predicts Resistance to Taxane-Containing Regimens in Triple Negative Breast Cancer During Neoadjuvant Chemotherapy
- (2015) Sadako Akashi-Tanaka et al. Clinical Breast Cancer
- FDA Approval Summary: Olaparib Monotherapy in Patients with Deleterious Germline BRCA-Mutated Advanced Ovarian Cancer Treated with Three or More Lines of Chemotherapy
- (2015) G. Kim et al. CLINICAL CANCER RESEARCH
- Quantitative site-specific ADP-ribosylation profiling of DNA-dependent PARPs
- (2015) Jean-Philippe Gagné et al. DNA REPAIR
- Discovery of 2-[1-(4,4-Difluorocyclohexyl)piperidin-4-yl]-6-fluoro-3-oxo-2,3-dihydro-1H-isoindole-4-carboxamide (NMS-P118): A Potent, Orally Available, and Highly Selective PARP-1 Inhibitor for Cancer Therapy
- (2015) Gianluca Papeo et al. JOURNAL OF MEDICINAL CHEMISTRY
- Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial
- (2015) Amit M Oza et al. LANCET ONCOLOGY
- Mechanistic Dissection of PARP1 Trapping and the Impact on In Vivo Tolerability and Efficacy of PARP Inhibitors
- (2015) T. A. Hopkins et al. MOLECULAR CANCER RESEARCH
- Structures and Mechanisms of Enzymes Employed in the Synthesis and Degradation of PARP-Dependent Protein ADP-Ribosylation
- (2015) Eva Barkauskaite et al. MOLECULAR CELL
- The Promise of Proteomics for the Study of ADP-Ribosylation
- (2015) Casey M. Daniels et al. MOLECULAR CELL
- Structural Basis of Detection and Signaling of DNA Single-Strand Breaks by Human PARP-1
- (2015) Sebastian Eustermann et al. MOLECULAR CELL
- PARP-1 Activation Requires Local Unfolding of an Autoinhibitory Domain
- (2015) Jennine M. Dawicki-McKenna et al. MOLECULAR CELL
- Homologous Recombination Deficiency: Exploiting the Fundamental Vulnerability of Ovarian Cancer
- (2015) P. A. Konstantinopoulos et al. Cancer Discovery
- Conformational Activation of Poly(ADP-ribose) Polymerase-1 upon DNA Binding Revealed by Small-Angle X-ray Scattering
- (2014) Steven O. Mansoorabadi et al. BIOCHEMISTRY
- Cancers associated withBRCA1andBRCA2mutations other than breast and ovarian
- (2014) Jacqueline Mersch et al. CANCER
- Distribution of protein poly(ADP-ribosyl)ation systems across all domains of life
- (2014) Dragutin Perina et al. DNA REPAIR
- POVME 2.0: An Enhanced Tool for Determining Pocket Shape and Volume Characteristics
- (2014) Jacob D. Durrant et al. Journal of Chemical Theory and Computation
- Discovery and Structure–Activity Relationship of Novel 2,3-Dihydrobenzofuran-7-carboxamide and 2,3-Dihydrobenzofuran-3(2H)-one-7-carboxamide Derivatives as Poly(ADP-ribose)polymerase-1 Inhibitors
- (2014) Maulik R. Patel et al. JOURNAL OF MEDICINAL CHEMISTRY
- Phosphoproteomic Approach to Characterize Protein Mono- and Poly(ADP-ribosyl)ation Sites from Cells
- (2014) Casey M. Daniels et al. JOURNAL OF PROTEOME RESEARCH
- Base Excision Repair Defects Invoke Hypersensitivity to PARP Inhibition
- (2014) Julie K. Horton et al. MOLECULAR CANCER RESEARCH
- Breast Cancer Resistance Protein (BCRP/ABCG2) and P-glycoprotein (P-GP/ABCB1) Restrict Oral Availability and Brain Accumulation of the PARP Inhibitor Rucaparib (AG-014699)
- (2014) Selvi Durmus et al. PHARMACEUTICAL RESEARCH
- Family-wide analysis of poly(ADP-ribose) polymerase activity
- (2014) Sejal Vyas et al. Nature Communications
- Structure-Based Druggability Assessment of the Mammalian Structural Proteome with Inclusion of Light Protein Flexibility
- (2014) Kathryn A. Loving et al. PLoS Computational Biology
- Poly (ADP) ribose polymerase enzyme inhibitor, veliparib, potentiates chemotherapy and radiation in vitro and in vivo in small cell lung cancer
- (2014) Taofeek K. Owonikoko et al. Cancer Medicine
- BRCAness: a deeper insight into basal-like breast tumors
- (2013) S. De Summa et al. ANNALS OF ONCOLOGY
- Targeting PARP-1 Allosteric Regulation Offers Therapeutic Potential against Cancer
- (2013) J. D. Steffen et al. CANCER RESEARCH
- PARP-1 mechanism for coupling DNA damage detection to poly(ADP-ribose) synthesis
- (2013) Marie-France Langelier et al. CURRENT OPINION IN STRUCTURAL BIOLOGY
- Deficiency of terminal ADP-ribose protein glycohydrolase TARG1/C6orf130 in neurodegenerative disease
- (2013) Reza Sharifi et al. EMBO JOURNAL
- Design, Synthesis, and Biological Evaluation of a Series of Benzo[de][1,7]naphthyridin-7(8H)-ones Bearing a Functionalized Longer Chain Appendage as Novel PARP1 Inhibitors
- (2013) Na Ye et al. JOURNAL OF MEDICINAL CHEMISTRY
- Mapping PARP-1 Auto-ADP-ribosylation Sites by Liquid Chromatography–Tandem Mass Spectrometry
- (2013) John D Chapman et al. JOURNAL OF PROTEOME RESEARCH
- Stereospecific PARP Trapping by BMN 673 and Comparison with Olaparib and Rucaparib
- (2013) J. Murai et al. MOLECULAR CANCER THERAPEUTICS
- Proteome-wide Identification of Poly(ADP-Ribosyl)ation Targets in Different Genotoxic Stress Responses
- (2013) Stephanie Jungmichel et al. MOLECULAR CELL
- Site-specific characterization of the Asp- and Glu-ADP-ribosylated proteome
- (2013) Yajie Zhang et al. NATURE METHODS
- Okazaki Fragment Metabolism
- (2013) L. Balakrishnan et al. Cold Spring Harbor Perspectives in Biology
- Repair of Double-Strand Breaks by End Joining
- (2013) K. K. Chiruvella et al. Cold Spring Harbor Perspectives in Biology
- Resistance to PARP-Inhibitors in Cancer Therapy
- (2013) Alicia Montoni et al. Frontiers in Pharmacology
- Structural Implications for Selective Targeting of PARPs
- (2013) Jamin D. Steffen et al. Frontiers in Oncology
- DoGSiteScorer: a web server for automatic binding site prediction, analysis and druggability assessment
- (2012) A. Volkamer et al. BIOINFORMATICS
- A Distinct Replication Fork Protection Pathway Connects Fanconi Anemia Tumor Suppressors to RAD51-BRCA1/2
- (2012) Katharina Schlacher et al. CANCER CELL
- Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors
- (2012) J. Murai et al. CANCER RESEARCH
- Evaluation of candidate biomarkers to predict cancer cell sensitivity or resistance to PARP-1 inhibitor treatment
- (2012) Lenka Oplustilova et al. CELL CYCLE
- Recognition of the iso-ADP-ribose moiety in poly(ADP-ribose) by WWE domains suggests a general mechanism for poly(ADP-ribosyl)ation-dependent ubiquitination
- (2012) Z. Wang et al. GENES & DEVELOPMENT
- On PAR with PARP: cellular stress signaling through poly(ADP-ribose) and PARP-1
- (2012) X. Luo et al. GENES & DEVELOPMENT
- Structure of mammalian poly(ADP-ribose) glycohydrolase reveals a flexible tyrosine clasp as a substrate-binding element
- (2012) In-Kwon Kim et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- FTMAP: extended protein mapping with user-selected probe molecules
- (2012) C. H. Ngan et al. NUCLEIC ACIDS RESEARCH
- Pleiotropic Cellular Functions of PARP1 in Longevity and Aging: Genome Maintenance Meets Inflammation
- (2012) Aswin Mangerich et al. Oxidative Medicine and Cellular Longevity
- Hyperactivation of PARP Triggers Nonhomologous End-Joining in Repair-Deficient Mouse Fibroblasts
- (2012) Natalie R. Gassman et al. PLoS One
- Structural Basis for DNA Damage-Dependent Poly(ADP-ribosyl)ation by Human PARP-1
- (2012) M.-F. Langelier et al. SCIENCE
- Loss of 53BP1 Causes PARP Inhibitor Resistance in Brca1 -Mutated Mouse Mammary Tumors
- (2012) Janneke E. Jaspers et al. Cancer Discovery
- The role of PARP in DNA repair and its therapeutic exploitation
- (2011) M Javle et al. BRITISH JOURNAL OF CANCER
- Crystal Structures of Poly(ADP-ribose) Polymerase-1 (PARP-1) Zinc Fingers Bound to DNA
- (2011) Marie-France Langelier et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Secondary Somatic Mutations Restoring BRCA1/2 Predict Chemotherapy Resistance in Hereditary Ovarian Carcinomas
- (2011) Barbara Norquist et al. JOURNAL OF CLINICAL ONCOLOGY
- The underlying mechanism for the PARP and BRCA synthetic lethality: Clearing up the misunderstandings
- (2011) Thomas Helleday Molecular Oncology
- The structure and catalytic mechanism of a poly(ADP-ribose) glycohydrolase
- (2011) Dea Slade et al. NATURE
- Nonhomologous end joining drives poly(ADP-ribose) polymerase (PARP) inhibitor lethality in homologous recombination-deficient cells
- (2011) A. G. Patel et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- BRCA1, PARP, and 53BP1: conditional synthetic lethality and synthetic viability
- (2011) A. Aly et al. Journal of Molecular Cell Biology
- Overview of Base Excision Repair Biochemistry
- (2011) Yun-Jeong Kim et al. Current Molecular Pharmacology
- Poly(ADP-Ribose) Polymerase Is Hyperactivated in Homologous Recombination-Defective Cells
- (2010) P. Gottipati et al. CANCER RESEARCH
- 53BP1 Inhibits Homologous Recombination in Brca1-Deficient Cells by Blocking Resection of DNA Breaks
- (2010) Samuel F. Bunting et al. CELL
- Synthetic lethality: General principles, utility and detection using genetic screens in human cells
- (2010) Sebastian M.B. Nijman FEBS LETTERS
- The Zn3 Domain of Human Poly(ADP-ribose) Polymerase-1 (PARP-1) Functions in Both DNA-dependent Poly(ADP-ribose) Synthesis Activity and Chromatin Compaction
- (2010) Marie-France Langelier et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Evolution of Poly(ADP-ribose) Polymerase-1 (PARP-1) Inhibitors. From Concept to Clinic
- (2010) Dana V. Ferraris JOURNAL OF MEDICINAL CHEMISTRY
- miR-182-Mediated Downregulation of BRCA1 Impacts DNA Repair and Sensitivity to PARP Inhibitors
- (2010) Patryk Moskwa et al. MOLECULAR CELL
- Parthanatos, a messenger of death
- (2009) Karen Kate David Frontiers in Bioscience-Landmark
- Identification of the ADP-Ribosylation Sites in the PARP-1 Automodification Domain: Analysis and Implications
- (2009) Zhihua Tao et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Acquired Resistance to Combination Treatment with Temozolomide and ABT-888 Is Mediated by Both Base Excision Repair and Homologous Recombination DNA Repair Pathways
- (2009) X. Liu et al. MOLECULAR CANCER RESEARCH
- Molecular mechanism of poly(ADP-ribosyl)ation by PARP1 and identification of lysine residues as ADP-ribose acceptor sites
- (2009) Matthias Altmeyer et al. NUCLEIC ACIDS RESEARCH
- Early steps in the DNA base excision/single-strand interruption repair pathway in mammalian cells
- (2008) Muralidhar L Hegde et al. CELL RESEARCH
- Poly(ADP-ribose) Polymerase-1 Down-regulates BRCA2 Expression through theBRCA2Promoter
- (2008) Jinhua Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Poly(ADP-ribose)-binding zinc finger motifs in DNA repair/checkpoint proteins
- (2008) Ivan Ahel et al. NATURE
- Resistance to therapy caused by intragenic deletion in BRCA2
- (2008) Stacey L. Edwards et al. NATURE
- Single-strand break repair and genetic disease
- (2008) Keith W. Caldecott NATURE REVIEWS GENETICS
- High sensitivity of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugs
- (2008) S. Rottenberg et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More